Toxicokinetics of [H]Microcystin-LR in Mice
Nancy A. Robinson H]MCYST-LR, sublethal, iv) were measured in mice. Plasma elimination was biexponential with a-and 0-phase half-lives of 0.8 and 6.9 min, respectively. The apparent volume of distribution of the P-phase was 10 ml and the bioavailability was 1036 pmol min/ml. At 60 min, liver contained 67 ± 4% of dose and the amount of hepatic radioactivity did not change through 6
days. Excretion of radiolabel, measured through 6 days, accounted for 23.7 ± 1.7% of the dose, with 9.2 ± 1 and 14.5 ± 1.1% in urine and feces, respectively. Approximately 60% of the urine and fecal radiolabel was parent. Hepatic cytosol, which contained 70 ± 2% of hepatic radiolabel, was prepared for HPLC analysis by heat denaturation, pronase treatment, and C-18 Sep Pak extraction. One hour post exposure, 35 ± 2% of the radiolabel was insoluble or C-18 Sep Pak-bound; 43 ± 3% was associated with a peak of retention time (rt) 6.6 min, and 16 ± 3% with parent. After 6 days, 8 ± 1% was C-18 Sep Pak-bound or insoluble; 5 ± 0% occurred at rt 6.6 min, 17 ± 1% with parent, and 60 ± 2% was associated with rt 8.1 min. Two other radioactive peaks, rt 4.9 and 5.6 min, appeared transiently. This study is the first to describe the long-term hepatic retention of MCYST toxin and documents a putative detoxification pathway.
INTRODUCTION

Microcystin-LR (MCYST-LR), isolated from the cyanobacterium
Microcystis aeruginosa strain PCC-7820, is one of several related cyclic hepatotoxins (Botes et al., 1985; Rinehart et al., 1988) .
This family of toxins has been implicated in the death of both wild and domestic animals that consumed water containing dense blooms of blue-green alga (Soll and Williams, 1985; Beasley et al., 1989; Galey et al., 1987) . A consistent pathological finding after lethal exposure to toxin is blood-engorged livers with diffuse hepatic centrilobular necrosis (Konst et al., 1965; Adams et al., 1988; Jackson et al., 1984; Theiss et al., 1988; Hooser et al., 1989) . The proposed cause of death is massive intrahepatic hemorrhage (Hooser et al., 1989; Theiss et al., 1988) . Human fatality has not been associated with the MCYST toxins; however, a heavy bloom of M. aeruginosa in a reservoir at Malpus Dam, Australia, was correlated with a rise in plasma gamma-glutamyl transpepidase in humans, suggestive of hepatic injury (Falconer et al., 1983) .
While information has been published concerning the tissue distribution of MCYST toxins in rat (Falconer et al., 1986; Pace et al., 1990b) and in mouse (Robinson et al., 1989; Brooks and Codd, 1987; Runnegar et al., 1986) , the toxicokinetics have not been completely described in either species. The liver, the target organ, accumulates toxin; however, the time required for maximal accumulation varies from 1 min (Brooks and Codd, 1987) to 60 min (Robinson et al., 1989) after ip administration in mice.
Additionally, metabolism and elimination of the toxin have not been measured comprehensively.
It is reasonable to propose that metabolism of MCYST-LR be necessary for its toxic effects to be expressed, based upon the following considerations: hepatic damage occurs in the centrilobular (perivenous) region, which is the location of the highest concentration of many metabolic enzymes (Jungermann and Katz, 1989) ; liver specificity could be explained by prerequisite hepatic metabolism for toxicity; and neonatal rats and mice are not as susceptible to the MCYST toxins (Foxall and Sasner, 1981; Stoner et al., 1989) , possibly because many metabolic enzymes are regulated developmentally (Pelkonen, 1979 Urine and feces were collected at 6 and 12 hr and 1, 2, 3, 4, 5, and 6 days post exposure. Sodium fluoride (25 mg) was added to the urine samples and 100-500 gi was analyzed for radioactivity.
The calculated limit of detection in urine was 1 pmol/ml. with a motor-driven, teflon pestle in 5 ml of 100 mM Tris-Cl, pH 7.2, and centrifuged at 10,000 x g for 10 min. The pellet was rehomogenized (3 ml buffer) and centrifuged as before. The combined supernatants were centrifuged at 100,000 x g to obtain the cytosolic fraction. The cytosol (1 ml) was heat-denatured for 30 min at 90 0 C after addition of an equal volume of 100 mM potassium phosphate, pH 7.5. Pronase (I mg in 1 ml buffer, Boehringer Mannhiem Biochemicals, Indianapolis, IN) was added to the heat-denatured slurry and the sample incubated for 1 hr at 37 0 C. The resulting solution was centrifuged to remove any particulate material and the supernatant chromatographed on C-18
Sep Pak cartridges. Radioactivity was eluted with methanol, and the sample concentrated and prepared for HPLC analysis, as described for fecal samples.
Analysis of hepatic cytosol by desalting chromatography.
Econo-Pac 1ODG disposable columns (Bio-Rad, Rockville Center, NY), supplied prepacked with Bio-Gel P-6 desalting gel, were used to analyze samples of hepatic cytosol (0.8 ml) isolated from livers 1 hr to 6 days post exposure to [ 3 H]MCYST-LR. Columns were prepared with 100 mM Tris-Cl, pH 7.2, according to manufacturer's direction, except that 0.8 ml of sample rather than 3 ml was applied to the columns. Fractions (1 ml) were collected and analyzed for radioactivity by liquid scintillation. 
RESULTS
General results
After an iv injection of a sublethal dose (35 gg/kg) of [ 3 H]MCYST-LR, the mice displayed normal behavior. Liver weight did not increase; and histologically, 1-60 min and 6 days postexposure, livers were normal. Plasma levels of LDH, SDH, and AST were normal at 1 hr, transiently increased at 6 hr (p<0.01, 10, 25, and 20-fold, respectively over control), and returned to normal by 12 hr. Levels of BUN and ALT were unaffected.
Clearance of toxin from plasma
The semilog plot of plasma concentration of toxin eauivalents versus time is shown in Fig. I . Rosults are presented as molar equivalents of toxin. The curve represents a biexponential decay with a maximum concentration of 428 pmol/ml.
The half-lives of the a phase (distribution) and the P phase were 0.8 and 6.9 min, respectively. The AUC, estimated by the trapezoid rule, was 1036 pmol min/ml, and clearance from plasma was 0.9 ml/min. The apparent volume of the central compartment and Vp were 2 and 10 ml, respectively.
Concentration of toxin in tissues
The concentration of toxin molar equivalents per gram of tissue over time is shown in Fig 2. In liver, there was a rapid uptake of radiolabel, which reached a maximum accumulation of 521 ± 14 pmol/g (71 ± 3% of dose) by 30 min. The half-life of uptake was 6.8 min. In kidney, the maximum concentration was achieved at 3 min (90 ± 7 pmol/g, 4.6 ± 0.6% of dose) followed by a decline in concentration until 20 min. The amount of radiolabel in gut reached a maximum at 30-40 min. In lung and carcass, the maximum amounts were measured at 3 min, after which the concentration declined. Spleen and heart did not contain measurable amounts of radioactivity. The distribution of radiolabel to tissues with time, presented as percent of injected dose, is shown in Table 1 . The overall recovery of radiolabel ranged from 74 to 101% of dose. The partition coefficients or distribution ratios (R,, ratio of mean concentration of toxin equivalents in tissue to that in plasma) are given in Table 2 .
There was accumulation of radioactivity in liver, -kidney, and intestine (ratio increased with time and was >1), but not in lung and carcass.
Excretion of [ 3 H]MCYST-LR in urine and feces.
Six days post-exposure to 35 pg/kg [ 3 H]MCYST-LR, 23.7 ± 1.7% of the radiolabel was eliminated (Fig 3, Panel A) ; 9.2 ± 1.0% and 14.5 ± 1.1% via urine and feces, respectively. The percent of dose that appeared in feces or urine per collection interval is given in Fig. 3 , panels B and C, respectively. The rate of elimination via feces was 0.9 and 0.5% per hr for 6 and 12 hr, and ca. 1% per day for the remaining 6 days. Within the first 12 hr, 74% of cummulative urinary excretion had occurred.
Metabolic fate of [ 3 H]MCYST-LR.
Urine samples collected 6 and 12 hr after toxin exposure were analyzed for metabolites by C-18 HPLC. At 6 hr, 6 ± 1% of the injected radiolabel was found in urine; and 63 ± 2% (n=7) of that was parent toxin, rt 9.4 min (Fig. 4, panel B) . The major portion of the remaining radiolabel (30 ± 4%) was associated with a peak of rt 4.5 min. There were also several minor peaks detected in some of the samples. Between 6 and 12 hr, 1.5 ± 0.4% of the radiolabel was excreted in urine. In the two samples that contained sufficient radioactivity to be analyzed, the profile was similar to that seen at 6 hr; 35% at rt 4.5 min and 63% as parent.
Feces collected 6 hr post injection contained 5 ± 1% of the injected radiolabel, 69 ± 3% of which was recovered for HPLC analysis. A typical radioactive profile for a 6-hr fecal sample is shown in Fig. 4 , panel C. Parent toxin, rt 9.4 min, comprised 63 ± 8% (n=6) of the radioactivity with the residual in five other peaks (legend of Fig. 4) . Between 6 and 12 hr, 2.9 ± 0.3% of the dose appeared in feces; 52 ± 4% was recovered for HPLC analysis, of which 76 ± 8% (n=6) was associated with parent toxin.
The total amount of liver-sequestered radiolabel did not change from 1 hr (67 ± 4%, n=6) to 6 days (66 ± 2%, n=3) postexposure, while carcass-associated radiolabel, comprised of all tissues except liver, decreased from 15 ± 2% at 1 hr to trace amounts by 4 days. The subcellular distribution of hepatic radiolabel also remained unchanged over 6 days; the 10,000 x g pellet, consisting of unbroken cells, mitochondria and plasma membrane, contained 13 ± 1%; the 100,000 x g pellet, composed mainly of microsomes, residual plasma membrane, and mitochondria, and 4 days, as did the 6.6 min HPLC peak. The 8.1-min fraction steadily increased while the 4.9-and 5.6-min peaks appeared at 6 hr and 12 hr, and disappeared after 2 and 6 days, respectively.
DISCUSSION
The kinetic parameters defined in this study indicate that plasma elimination did not reflect toxicity, as liver, the target organ, accumulated the toxin. Hepatic accumulation of [ 3 H]MCYST-LR has been observed by several groups (Pace et al., 1990a,b; Robinson et al., 1989; Brooks and Codd, 1987; Runnegar et al., 1986; Falconer et al., 1986) ; however, this is the first time that the long-term hepatic retention of radiolabel has been documented. Runnegar et al. (1986) , who studied liver retention Fecal elimination, after the first 12 hr, was constant at -1% per day; but the amount of hepatic radiolabel did not change over the course of the study. There was, however, a decrease in carcass (all tissues except liver) radioactivity over time, but it is not clear whether the radiolabel was eliminated directly or via bile. It is possible that toxin was taken up by gut (8.6 ± 0.7% was found in gut at 1 hr) and subsequently excreted directly into the intestinal lumen and then eliminated in feces.
The major portion of urinary excretion occurred early and accounted for 9% of the dose. The limited urinary excretion is likely due to the rapid decline in plasma radiolabel. The halflife of the P phase of the plasma concentration curve and the hepatic uptake half-life were identical, -7 min, indicating that liver was the major factor in the plasma elimination of [ 3 H]MCYST-LR. This is not surprising, as extravascular tissue binding is known to be a principle determinate of the apparent half-life of xenobiotics if Vp is >100 ml/kg. Drugs such as rifampicin that inhibit hepatic uptake of toxin (Pace et al., 1990a; Runnegar et al., 1981) increase its bioavailability and thus may increase the total urinary excretion.
Unlike the hepatic-cytosolic radiolabel, urine and fecal radiolabel did not appear to be protein bound. Most of the radioactivity in both urine and feces was parent toxin (approximately 60%) and the metabolites that were detected did not appear to correlate with those seen in liver.
This study is the first to characterize over time the From the data presented in this study, it is clear that MCYST-LR forms a strong association with cytosolic protein.
Preliminary results from a subsequent study suggest that the association is covalent. 
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